PRLD · Prelude Therapeutics Inc · Analyst Estimates
Market Cap
$366.30M
Shares
79.80M
Analyst Estimates
Compare analyst forecasts for Prelude Therapeutics Inc across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Only independently verified consensus published through the company's investor-relations sources is available.
Consensus not yet available
Only independently verified consensus published through the company's investor-relations sources is available.
Key facts
CIK
1678660
CUSIP
74065P101
13F (30d)
49 filings
49 filers
Visit website
Investor relations